EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hyperglycemia Leads to BMSC Impaired Osteogenesis, Enhanced Adipogenesis, and Altered Metabolism

Suzanna Shirazi, Ezaldeen Esawi iD, Zeyad D Nassar, Stan Gronthos iD, Dimitrios Cakouros

Journal of Cellular Biochemistry · 2026-04 · 127 (4)

DOI: 10.1002/jcb.70090 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular Biochemistry, online erschienen am 25.04.2026. Verfasst von Suzanna Shirazi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Mesenchymal Stem Cell Laboratory, School of Pharmacy and Biomedical Sciences, College of Health, Adelaide University, South Australia, Australia. Hauptthemen laut MEDLINE: Osteogenesis, Adipogenesis, Mesenchymal Stem Cells, Hyperglycemia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, Medical Research Future Fund, University of Adelaide International Postgraduate Scholarship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes is a major risk factor for osteoporosis, which negatively impacts bone health, but the mechanisms underlying the effects of hyperglycemia on bone marrow mesenchymal/stromal cells (BMSC) are not fully understood. This study investigated how high glucose levels influence BMSC differentiation, proliferation, viability, and metabolism. The results demonstrated that high glucose inhibits osteogenesis in human BMSC, as evidenced by reduced alkaline phosphatase activity, impaired calcium deposition, and downregulation of key osteogenic genes (RUNX2, ALP). Conversely, high glucose conditions promoted adipogenesis, characterized by increased percentage of cells with lipid droplets, and upregulation of adipogenic genes (PPARγ2, CEBPα, AdipoQ), suggesting a shift towards fat cell differentiation. Furthermore, BMSC cultured in high glucose showed decreased proliferation, elevated DNA damage, increased oxidative stress, enhanced apoptosis and senescence, particularly in later passages, highlighting the negative impact of hyperglycemia on BMSC viability. Metabolomic profiling of osteogenic and adipogenic differentiation in normal and high glucose conditions revealed key metabolic shifts, with nicotinamide adenine dinucleotide (NAD+) and l ‐glutamate/α‐ketoglutarate (α‐KG) identified as critical metabolites driving these processes. Supplementation with NAD+ and α‐KG in high glucose conditions significantly enhanced ALP activity. These findings suggest that high glucose promotes adipogenesis at the expense of osteogenesis, exacerbating cellular damage and accelerating aging in BMSC. The identification of NAD+ and α‐KG as key regulators in this process provides new insights into the metabolic mechanisms behind impaired bone health in diabetes and highlights potential therapeutic avenues to counteract these detrimental effects to better manage diabetes‐related bone diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteogenesisAdipogenesisMesenchymal Stem CellsHyperglycemiaHumansCell DifferentiationGlucoseCell ProliferationCells, CulturedOxidative Stress

Stichwörter der Autor:innen

BMSCadipogenesisbonehyperglycemiamesenchymal/stromal stem cellsmetabolitesosteogenesis

Substanzen

Glucose

Autor:innen und Institutionen

  • Mesenchymal Stem Cell Laboratory, School of Pharmacy and Biomedical Sciences, College of Health, Adelaide University, South Australia, Australia.
  • Solid Tumour Program, Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.
  • South Australian ImmunoGENomics Cancer Institute, Adelaide University, Adelaide, South Australia, Australia.

ORCID-Profile: Ezaldeen Esawi, Stan Gronthos

Förderung

  • National Health and Medical Research Council
  • Medical Research Future Fund
  • University of Adelaide International Postgraduate Scholarship

Zitieren

APA

Shirazi, S., Esawi, E., Nassar, Z. D., Gronthos, S., & Cakouros, D. (2026). Hyperglycemia Leads to BMSC Impaired Osteogenesis, Enhanced Adipogenesis, and Altered Metabolism. Journal of Cellular Biochemistry, 127(4). https://doi.org/10.1002/jcb.70090

Vancouver

Shirazi S, Esawi E, Nassar ZD, Gronthos S, Cakouros D. Hyperglycemia Leads to BMSC Impaired Osteogenesis, Enhanced Adipogenesis, and Altered Metabolism. Journal of Cellular Biochemistry. 2026;127(4). doi:10.1002/jcb.70090

BibTeX
@article{Shirazi2026,
  author = {Shirazi, Suzanna and Esawi, Ezaldeen and Nassar, Zeyad D and Gronthos, Stan and Cakouros, Dimitrios},
  title = {Hyperglycemia Leads to BMSC Impaired Osteogenesis, Enhanced Adipogenesis, and Altered Metabolism},
  journal = {Journal of Cellular Biochemistry},
  year = {2026},
  volume = {127},
  number = {4},
  doi = {10.1002/jcb.70090}
}
Kostenlos starten →